#coronavirus treatment side effects
Explore tagged Tumblr posts
Text
THE BENEFITS OF IVERMECTIN. IF YOU HAVE CANCER, FREQUENT COLD OR INFECTIONS, MUSCLE SHRINKAGE, CARDIAC ISSUES, CROHNS, HERPES, ETC.
The study was published in the Cureus Journal of Medical Science. LET'S TALK ABOUT IVERMECTIN 1 – Ivermectin prevents the damage caused to RNA Vaccines. 2 – Ivermectin blocks the entry of Spike Protein into cells. So, if the person was vaccinated with COVID, they have hope, they have a way to treat themselves through Ivermectin. 3 – Ivermectin is a treatment after Covid and after vaccination, it is an effective medicine in all phases of Covid 19, even before entering the cell, Ivermectin already destroys the virus in the blood. It only has beneficial effects and no harmful effects in the treatment of the coronavirus. 4 – Ivermectin has a very powerful anti-inflammatory action against Coronavirus. 5 – Ivermectin has a powerful action for traumatic and orthopedic injuries, it strengthens muscles and has no side effects like corticosteroids. 6 – Ivermectin treats autoimmune ailments such as: rheumatoid arthritis, ankylosing spondylitis, fibromyalgia, psoriasis, Crohn's disease, allergic rhinitis. 7 – Ivermectin reduces the frequency of flu and colds. 8 – Ivermectin improves the immunity of cancer patients. 9 – Ivermectin treats Herpes Simplex and Herpes Zoster. 10 – Ivermectin reduces the frequency of sinusitis and diverticulitis. 11 – Ivermectin protects the heart in cardiac overload, in an embolism for example, it prevents cardiac hypoxia because it stimulates the production of basic energy so that the tissue is not destroyed and thus improves cardiac function. 12 – Ivermectin is antiparasitic. 13 – Ivermectin is anti-neoplastic (anti-cancer), it suppresses the proliferation and metastasis of cancer cells, only killing cancer cells and preserving healthy cells, improving the effectiveness of chemotherapy treatment, as it kills cancer cells resistant to chemotherapy, defeating the resistance to multiple chemotherapeutics that tumors develop, and combined with chemotherapy and/or anti-cancer agents, it provides an increase in the effectiveness of these treatments. 14 – Ivermectin is antimicrobial (bacteria and viruses), and increases immunity. 15 – Ivermectin reaches the Central Nervous System and regenerates the nerves. 16 – Ivermectin regulates glucose and insulin metabolism. 17 – Ivermectin regulates cholesterol metabolism. 18 – Ivermectin reduces liver fat in steatose. 19 – Ivermectin protects the liver exposed to insecticides. 20 – Ivermectin attacks the virus wherever it is, regardless of mutations. 21 – Ivermectin serves for the prevention and treatment of coronavirus, surprisingly. Unproven efficacy is not of Ivermectin, but of vaccines. 22 – Ivermectin, used as a prophylactic agent, was associated with a significant reduction in infection, hospitalization and mortality rates due to COVID-19. 23 - Ivermectin does not attack the liver, since it is not metabolized in it, and if in the intestine, on the contrary, it protects the liver.
BIG PHARMA DOES NOT WANT YOU TO KNOW THIS.THEY WANT TO SELL YOU THE EXPENSIVE MEDS THEY MAKE BILLIONS ON.
Please read, save and re-blog before Tumblr takes this down.
#ivermectin#big pharma lobby#big pharma#the great awakening#government corruption#covid vaccine#covid 19#covid 19 vaccine#covid#cardiac arrest#cardiac issues#crohns#diabetes#orthopedics#herpes
1K notes
·
View notes
Text
Also preserved in our archive
Listen at the first link!
The GIST
Recent studies suggest that a hypermetabolic state that damages the mitochondria results in a hypometabolic state in chronic fatigue syndrome (ME/CFS), long COVID, and fibromyalgia (FM). They also suggest that something in the blood, serum, or plasma is damaging the mitochondria in these diseases.
We’re not done with the mitochondria, though – far from it! Now we look at a bevy of recent long-COVID mitochondrial studies suggesting that mitochondrial dysfunction affects more than energy production and which illuminate what may have gone wrong in the mitochondria.
Muscle biopsies of 120 long-COVID patients who had ended up in the ICU found that a year later their muscles had higher levels of immune cells involved in tissue repair and reduced activity of the 2nd and fourth mitochondrial complexes. The authors concluded that there was “aberrant repair and altered mitochondrial activity in skeletal muscle.”
They couldn’t explain how a respiratory illness affected the muscles but a subsequent study did. A hamster model found that the coronavirus suppressed the genes associated with the muscle fibers, protein production, both sides of the mitochondrial energy production process (Krebs cycle and electron transport chain), and fat breakdown.
As it was doing that, it unleashed a barrage of inflammatory factors (IFN-α, IFN-γ, and TNF-α) which triggered a shift from relying mostly on aerobic energy production to the less effective process of anaerobic energy production (glycolysis).
The authors concluded that using treatments “that can boost mitochondrial functions, enhance protein synthesis, and inhibit protein degradation” may be useful for treating muscle fatigue in long COVID.
Next, a muscle study assessing “maximal fatty acid oxidation (MFO)” (i.e. energy produced by the breakdown of fats during exercise) found significantly reduced levels of fatty acid oxidation in long COVID and a “premature shift” from relying on fats to carbohydrates to powering their cells.
This was important because the body prefers to burn fats during exercise and because fats play key roles in both parts of the mitochondrial energy production process. The finding wasn’t so surprising, though. Problems with carnitine – which transports fatty acids into the mitochondria – have popped up in both long COVID and ME/CFS – suggesting that the fatty acids that power the mitochondria during exercise may not be getting into them.
A review paper asserted that increased free radical production (reactive oxygen species (ROS)) by the mitochondria both pushes the cell into a state of anaerobic energy production but also pushes the immune system to activate the inflammatory or innate immune response and away from the adaptive immune response that targets pathogens. This benefits the viruses by providing the substrates they need to grow and allows them to escape from the immune system.
Several researchers, including Avindra Nath, believe that the immune system tries to compensate for the impaired adaptive immune defense by ramping up the innate immune response. Nath believes this shift plays a central role in ME/CFS.
They proposed that treatments to boost mitochondrial functioning and reduce the production of mitochondrial reactive oxygen species (ROS) (free radicals) will be beneficial.
Lastly, a review asserted that the predominant view of the mitochondria as the main energy producers of the cell is misguided and incomplete. Harkening back to Naviaux’s characterization of the mitochondria as the primary threat-sensing part of the cell, the authors believe the mitochondria regulate the “physiological processes at the level of the cell, organ and organism”; i.e. the mitochondrial problems affect much more than low energy levels and fatigue.
A blog on red light/infrared light therapy – which could both boost mitochondrial health and antioxidant defenses – is coming up.
Full text at either link! There's a lot more than the gist
#long covid#covid is airborne#pandemic#mask up#covid#wear a mask#public health#covid 19#wear a respirator#still coviding#coronavirus#sars cov 2
39 notes
·
View notes
Text
Hufvudstadsbladet writes that Alexander Stubb took Åland by storm during his first visit there as president on Tuesday.
Describing it as a "charm visit" the paper features a photo of a seemingly endless queue in the main square in the capital, Mariehamn, of people lined up to take selfies with the president.
Hufvudstadsbladet also points to a more serious side to the visit, writing that Stubb said exactly what the Ålanders wanted to hear — the demilitarised status of the autonomous region is not a problem, and that having reviewed Finland's defence plans for Åland, he sleeps well at night.
Iltalehti reports that the president's press conference in Mariehamn on Tuesday was mainly focused on current foreign and security policy issues.
Asked about his statements to the French newspaper Le Monde regarding possible peace talks between Ukraine and Russia, he stood by his position, stressing that any decision on whether or not to start a negotiation process is in Ukraine's hands.
In reference to the counter-attack by Ukraine in Kursk, Stubb said that Finland would not impose restrictions on the use of the arms it supplies to Ukraine.
"Ukraine has every right to defend itself within the framework of international law," said President Stubb.
Potential for sabotage
Several papers picked up on a report first published online on Tuesday afternoon by Helsingin Sanomat saying that the Finnish Security Intelligence Service (Supo) sees Finnish arms aid to Ukraine as a target of potential Russian sabotage.
This summer, Finland sent its 24th shipment of arms aid to Ukraine. Officials have not revealed any details about their content or, for example, the mode of shipment.
The total value of all defence materials sent from Finland to Ukraine now stands at 2.2 billion euros.
Helsingin Sanomat quotes Supo researcher Lotta Hakala as saying that there are no signs of anything unusual concerning the logistics, storage and transport of Finland's arms aid. However, Supo has now publicly said they are potential targets for sabotage.
Supo has also found no evidence of Russian involvement in recent break-ins and vandalism at some water processing facilities in Finland.
The Security Intelligence Service adds, though, that Russia is trying to influence public opinion in countries that support Ukraine in order to create a climate of fear and uncertainty aimed at eroding popular support for Ukraine.
Covid up, but most cases mild
The number of cases of coronavirus infection is on the rise in Finland, but according to the National Institute for Health and Welfare (THL) symptoms seem to be less severe than in the past, and people are less likely to seek hospital treatment.
Ilta-Sanomat looks at the situation after asking readers to tell the paper about their experiences with covid over the summer, and receiving more than 600 responses by early this week.
The vast majority of respondents said they had mild symptoms after being infected. The most common symptoms included fever, headache, fatigue, cough, runny nose and muscle aches.
This is all very similar to the effects of a common cold.
Around 30 covid deaths were recorded in Finland between June and July this year, compared with over 120 in the same period last year.
Ilta-Sanomat notes that THL specialists have said that for the elderly or others in poor health Covid, like other infections, can still pose a serious and require hospitalisation.
Urban legend debunked
Have you heard of the old lady who feeds bread crumbs to birds from a large bag in Helsinki's central park? The story goes that she wears a black coat and a black scarf in summer and winter and doesn't say a word. If anyone approaches her, she vanishes.
Or how about the treasure hidden under what is now the Laajasalo bridge, stashed away by Carl Olof Cronstedt, a Vice-Admiral in the Swedish Navy? Cronstedt surrendered what is now the Suomenlinna fortress to Russian besiegers in 1808, and the story goes that first, he hid a huge bribe that he received for raising a white flag.
These are a few of the urban legends Helsingin Uutiset mentions before delving into its own investigation of one more — a longstanding rumour that the Helsinki House of Culture is home to an infestation of venomous spiders.
It is a fact that sometime during the 1970s a few Chilean recluse spiders apparently hitched a ride in a crate from South America to Helsinki's Museum of Natural History and established a small colony in the building.
HU set out to find investigate whether there is any truth to claims that something similar happened at the House of Culture.
The facilities production manager, Antti Sarmanne, claims to have seen the spiders several times in well over 20 years on the job.
"I think they came long before me. The story goes that the spiders came to the House of Culture in the equipment of a foreign artist, or from an exhibition," he said.
A thorough search by HU of the cellar's nooks and crannies found spiders, and spiders of more than one species, but none of them exotic or venomous.
Chilean recluse spiders have not been seen outside the Natural History Museum, its curator Timo Pajunen assured HU. During the 1990s, a spider was sent from the House of Culture to the museum for identification and it turned out to be a common house spider.
Helsingin Uutiset's conclusion is that whispers of deadly creepy-crawlers in the House of Culture can safely be ignored.
4 notes
·
View notes
Text
Extracts of the the Judge’s reasoning and analysis:
On November 4, 2020, Plaintiff Brianne Dressen received AstraZeneca’s experimental COVID vaccine as part of a clinical trial in Salt Lake County. 4 Velocity Clinical Research, Inc. (Velocity) administered the trial on AstraZeneca’s behalf. 5 Before receiving the inoculation, Dressen signed an informed consent form (ICF) that outlined her rights and responsibilities as a trial participant and disclosed possible side effects of the vaccine.6 Under the terms of the ICF, the parties agreed AstraZeneca would “reimburse[] for time and travel in the amounts of $125.00 per each completed study visit and $30.00 for each completed phone call.”7 The parties also agreed that a “study doctor” would “provide medical treatment or refer [Dressen] for treatment” if Dressen became ill or injured while participating in the study.8 Additionally, AstraZeneca disclosed that it had an insurance policy to “cover the costs of research injuries as long as [Dressen] followed [the] study doctor’s instructions.”9 AstraZeneca confirmed it would “pay the costs of medical treatment for research injuries, provided that the costs are reasonable, and [Dressen] did not cause the injury [her]self.”10 At the same time, the parties agreed federal law may limit Dressen’s right to sue for injuries caused by the vaccine: Due to the coronavirus public health crisis, the federal government has issued an order that may limit your right to sue if you are injured or harmed while participating in this COVID-19-related clinical study. If the order applies, it limits your right to sue the researchers, healthcare providers, any Sponsor or manufacturer or distributor involved with the Study. You may be prevented from making claims for injuries that have a causal relationship with the use of the investigational product in this Study, including, but not limited to, claims for death; physical, mental, or emotional injury, illness, disability, or condition; fear of physical, mental, or emotional injury, illness, disability, or condition, including any need for medical monitoring; and loss of or damage to property, including business interruption loss. However, the federal government has a program that may provide compensation to you or your family if you experience serious physical injuries or death. If funds are appropriated by Congress, compensation for injuries may be available to you under this Countermeasures Injury Compensation Program.11 Within an hour of receiving the vaccine, Dressen’s right arm began tingling.12 The sensation, a condition called paresthesia, soon spread to her right shoulder and left arm.13 Later the same day, Dressen began experiencing a host of other symptoms, including blurred vison, tinnitus, nausea, and sound sensitivity.14 Dressen first visited an emergency room three days after receiving the vaccine.15 The doctor who treated her diagnosed her with a “vaccine reaction.”16 She returned to the emergency room four days later, and the next day she visited a nurse practitioner at Utah Valley Neurological who diagnosed her with an “immunization reaction.”17 Thirteen days after receiving the vaccine, Dressen visited an otolaryngologist to seek care for “acute sensitivities to light and sound.”18 The doctor noted Dressen was suffering from “a likely side effect due to an increased immune response to the vaccine.”19
2 notes
·
View notes
Text
THE BENEFITS OF IVERMECTIN. IF YOU HAVE CANCER, FREQUENT COLD OR INFECTIONS, MUSCLE SHRINKAGE, CARDIAC ISSUES, CROHNS, HERPES, ETC.
The study was published in the Cureus Journal of Medical Science. LET'S TALK ABOUT IVERMECTIN 1 – Ivermectin prevents the damage caused to RNA Vaccines. 2 – Ivermectin blocks the entry of Spike Protein into cells. So, if the person was vaccinated with COVID, they have hope, they have a way to treat themselves through Ivermectin. 3 – Ivermectin is a treatment after Covid and after vaccination, it is an effective medicine in all phases of Covid 19, even before entering the cell, Ivermectin already destroys the virus in the blood. It only has beneficial effects and no harmful effects in the treatment of the coronavirus. 4 – Ivermectin has a very powerful anti-inflammatory action against Coronavirus. 5 – Ivermectin has a powerful action for traumatic and orthopedic injuries, it strengthens muscles and has no side effects like corticosteroids. 6 – Ivermectin treats autoimmune ailments such as: rheumatoid arthritis, ankylosing spondylitis, fibromyalgia, psoriasis, Crohn's disease, allergic rhinitis. 7 – Ivermectin reduces the frequency of flu and colds. 8 – Ivermectin improves the immunity of cancer patients. 9 – Ivermectin treats Herpes Simplex and Herpes Zoster. 10 – Ivermectin reduces the frequency of sinusitis and diverticulitis. 11 – Ivermectin protects the heart in cardiac overload, in an embolism for example, it prevents cardiac hypoxia because it stimulates the production of basic energy so that the tissue is not destroyed and thus improves cardiac function. 12 – Ivermectin is antiparasitic. 13 – Ivermectin is anti-neoplastic (anti-cancer), it suppresses the proliferation and metastasis of cancer cells, only killing cancer cells and preserving healthy cells, improving the effectiveness of chemotherapy treatment, as it kills cancer cells resistant to chemotherapy, defeating the resistance to multiple chemotherapeutics that tumors develop, and combined with chemotherapy and/or anti-cancer agents, it provides an increase in the effectiveness of these treatments. 14 – Ivermectin is antimicrobial (bacteria and viruses), and increases immunity. 15 – Ivermectin reaches the Central Nervous System and regenerates the nerves. 16 – Ivermectin regulates glucose and insulin metabolism. 17 – Ivermectin regulates cholesterol metabolism. 18 – Ivermectin reduces liver fat in steatose. 19 – Ivermectin protects the liver exposed to insecticides. 20 – Ivermectin attacks the virus wherever it is, regardless of mutations. 21 – Ivermectin serves for the prevention and treatment of coronavirus, surprisingly. Unproven efficacy is not of Ivermectin, but of vaccines. 22 – Ivermectin, used as a prophylactic agent, was associated with a significant reduction in infection, hospitalization and mortality rates due to COVID-19. 23 - Ivermectin does not attack the liver, since it is not metabolized in it, and if in the intestine, on the contrary, it protects the liver.
2 notes
·
View notes
Text
My dad was diagnosed with Stage 4 Prostate Cancer in February 2020 (perfect timing from the universe if you remember a little thing called the Coronavirus pandemic which shut down the entire world a month later). If caught early prostate cancer is one of the more treatable cancers, usually involving surgery to remove the prostate.
My dad was not so lucky, and by his own admission had been ignoring symptoms and problems for a long time, so his disease was too advanced for that type of treatment and upon his initial diagnosis the cancer was spread to bones in his hips and ribs.
But he has a terrific oncologist, and had very good health benefits through his then employer the University of Texas, so they started him on a mixture of chemo and hormone therapy and he responded very well to it. It was definitely rougher at some points, the side effects making him very weak and sickly.
Over that first year of his cancer battle I had been preparing myself as much as I could mentally and emotionally to lose my father. But he got better and eventually they were able to take him off most treatments for up to six months at a time.
The last few months some of his test results were becoming concerning, so they had him do a full body scan on Monday this week to see if the cancer had spread anymore. Thankfully we just got the news today the cancer has not spread; so they will restart him on his six months on/six months off regiment and will be giving him a new medication that should have less side effects.
We had been told his chances of making it 5 years after the diagnosis were good, and he’s almost there. Making it to the ten years the odds are not as great, but we’re happy he’s still with us for now. And at least one of the loads bearing down on me in life right now feels a bit lighter.
2 notes
·
View notes
Text
Stay Ahead of Sickness: Prevent Diseases with These Simple Health Hacks!
Prevention is better than cure – a phrase we’ve all heard before, but how many of us truly embrace it? In a world where health is often overlooked until sickness strikes, taking proactive measures like regular medical check-ups, vaccinations, and adopting a balanced lifestyle can make all the difference. This guide will show you how to protect your sanatate, explore remedii naturiste, and understand the importance of teste medicale (medical tests) to stay one step ahead of illnesses.
1. Why Preventive Healthcare is Crucial
Preventive care helps identify and address potential health issues before they become serious. Regular check-ups, vaccinations, and early screenings reduce the risk of chronic conditions, such as heart disease, diabetes, and cancer. Here's why prevention matters:
Saves money by reducing costly treatments.
Prolongs life expectancy.
Improves overall quality of life.
When paired with lifestyle changes, preventive healthcare is the ultimate solution for long-term well-being.
2. Prioritize Regular Medical Tests
Medical tests are the foundation of disease prevention. They help identify issues like high cholesterol, blood sugar imbalances, and other risk factors early. Some essential teste medicale include:
Blood pressure monitoring: Detects hypertension risks.
Blood tests: Measures cholesterol, glucose levels, and vitamin deficiencies.
Cancer screenings: Essential for early detection of breast, cervical, or colon cancers.
Regular screenings combined with advice from your doctor ensure your body remains in peak condition. Make these tests part of your health routine and track results in a dictionar sanatate for easy reference.
3. Adopt a Healthy Lifestyle
A healthy lifestyle is your first line of defense against illness. Here’s how to incorporate healthy habits into your daily life:
Balanced diet: Focus on fresh fruits, vegetables, whole grains, and lean proteins. Avoid processed foods and excess sugar.
Regular exercise: Engage in at least 30 minutes of moderate activity daily to boost immunity and cardiovascular health.
Adequate sleep: 7-9 hours of quality sleep helps the body recover and fight diseases.
Stress management: Practice meditation, yoga, or breathing exercises to maintain mental well-being.
Combining these steps creates a strong foundation for your sanatate and resilience against future illnesses.
4. Leverage Natural Remedies for Added Protection
In addition to modern medicine, remedii naturiste (natural remedies) can complement your health routine. These remedies often strengthen immunity and promote healing without side effects. Popular options include:
Herbal teas: Green tea and chamomile support digestion and relaxation.
Superfoods: Turmeric, ginger, and garlic possess anti-inflammatory and antioxidant properties.
Essential oils: Lavender and eucalyptus oils improve sleep and respiratory health.
Probiotics: Foods like yogurt and fermented vegetables boost gut health, which is closely linked to overall immunity.
When used alongside preventive measures, these natural solutions provide extra layers of protection for your health.
5. Stay Vaccinated to Protect Against Diseases
Vaccines are one of the most effective tools for disease prevention. They protect not just you but also your community by reducing the spread of infections. Key vaccines to consider include:
Influenza vaccine: Annual flu shots are essential, especially for vulnerable groups.
HPV vaccine: Prevents cervical cancer and other HPV-related conditions.
COVID-19 vaccine: Protects against severe complications of coronavirus.
Hepatitis vaccines: Safeguards liver health by preventing hepatitis A and B.
Talk to your doctor about the vaccines you may need based on your age, health history, and lifestyle.
6. Monitor Your Progress with a Health Dictionary
Tracking your health journey is easier than ever. Use a dictionar sanatate (health dictionary) or digital tools to log medical test results, vaccination records, and lifestyle changes. This allows you to:
Spot trends in your health over time.
Share accurate information with healthcare professionals.
Stay motivated to achieve long-term health goals.
Final Thoughts
Your health is your greatest asset, and taking preventive measures is the best way to protect it. Regular teste medicale, vaccinations, and adopting a healthy lifestyle form the backbone of effective disease prevention. Don’t wait for symptoms to appear – act now and embrace a proactive approach to wellness.
With the right mix of modern medicine, remedii naturiste, and health tracking, you can achieve a balanced and disease-free life. Start your journey today by scheduling a check-up, exploring natural remedies, and creating your personalized dictionar sanatate.
#DiseasePrevention#HealthyLiving#StayHealthy#PreventIllness#MedicalTests#VaccinationsMatter#NaturalRemedies#HolisticHealth#HealthyLifestyle#WellnessJourney#SelfCareTips#HealthTracking#ImmuneBoost#SanatateTips#HealthyHabits#ProactiveHealth#NaturalHealing#PreventativeCare#MindBodyHealth#HealthFirst#BalancedLiving#StayWell#BetterHealthTips#RemediiNaturiste
0 notes
Text
My fellow medics, this is must-read for you:
"The House Select Subcommittee on the Coronavirus Pandemic has completed its two-year investigation and released its final report.
The team prepared more than 100 investigative letters, conducted more than 30 transcripts of interviews and depositions, and held 25 hearings and meetings, reviewing more than a million pages of documents.
Key Points:
1. The virus has biological characteristics that are not found in nature. The first people to become ill were the lab workers themselves.
2. The publication “The Proximal Origin of SARS-CoV-2,” which has been repeatedly used by officials to discredit the lab leak theory, was called out by Dr. Fauci to promote the preferred theory that COVID-19 originated in nature.
3. EcoHealth, led by Dr. Peter Daszak, used U.S. taxpayer dollars to support dangerous research in China.
4. The NIH’s procedures for funding and overseeing potentially dangerous research are flawed, unreliable, and pose a serious threat to both public health and national security.
5. The Paycheck Protection Program, which offered Americans significant relief in the form of forgivable loans, was rife with fraud, resulting in at least $64 billion in lost taxpayer money.
6. Fraudsters cost American taxpayers more than $191 billion; at least half of the money lost in relief programs was stolen by international fraudsters.
7. The COVID-19 vaccine did not stop the spread or transmission of the virus as promised.
8. The FDA rushed to approve a COVID-19 vaccine. Two top FDA scientists have warned their colleagues about the dangers of rushing the vaccine approval process and the potential for side effects. They were ignored, and mandatory vaccinations were introduced within days. (Remember, these same scientists resigned from the FDA COVID-19 vaccine task force.)
9. Vaccine requirements were not supported by science and did more harm than good.
10. Public health officials made a concerted effort to ignore natural immunity from COVID-19 when developing vaccination recommendations and requirements, and they often spread misinformation through conflicting messages and lack of transparency.
11. Vaccine injury reporting systems have created confusion, failed to adequately inform the American public, and undermined public trust in vaccine safety during the covid-19 pandemic.
12. As a result of school closures, students have faced historic learning loss, higher rates of psychological distress, and worse physical well-being. Standardized test results show that children have lost decades of academic progress, and mental and physical health problems have also increased dramatically, with suicide attempts among girls aged 12-17 up 51%.
Full report here (520 pages): - https://oversight.house.gov/wp-content/uploads/2024/12/12.04.2024-SSCP-FINAL-REPORT.pdf
It's worth remembering how some of our so-called “Doctors” (Ukrainian) called in intensive care units (!) not to provide medical care to the unvaccinated... I’d better keep silent about the rest of the bacchanalia, the fruits of which we are still reaping, so as not to open the wounds.
"There have been previous reports of the long-term presence of s-protein in the body after immunization and large amounts of foreign DNA in the drug, since the end of 2022 this is a new study.
"We analyzed the contents of RNA and DNA in the vials and detected large amounts of DNA after RNAse treatment in all batches with concentrations ranging from 32.7 ng to 43.4 ng per clinical dose. This far exceeds the maximum permissible concentration of 10 ng per clinical dose established by international regulatory authorities.
Genetic analysis with selected pairs of PCR primers proved that the residual DNA is not only fragments of DNA templates encoding the s-protein, but also all genes from the plasmid, including the sv40 promoter/enhancer (unfortunately, highly oncogenic) and the antibiotic resistance gene."
https://publichealthpolicyjournal.com/biontech-rna-based-covid-19-injections-contain-large-amounts-of-residual-dna-including-an-sv40-promoter-enhancer-sequence/
In Germany, the Institute for Molecular Diagnostics (Inmodia GmbH) offers tests to determine the presence of vaccine proteins or DNA plasmids in the human body:
"We focus on detecting spike proteins in tissue samples (including tumor material), measuring the concentration of spike proteins in blood or cerebrospinal fluid (including immune cells), and detecting "vaccine mRNA" and residual DNA (plasmid DNA).
We focus on finding out whether the sample contains spike proteins and whether they come from a COVID-19 injection or from a natural infection."
https://inmodia.de/en/
0 notes
Text
Oncology Precision Medicine Market To Showcase Strong Growth Owing To Rising Demand For Targeted Cancer Therapies
The Oncology Precision Medicine Market has been growing at a steady pace owing to the increasing prevalence of various types of cancers and the need for more effective treatment options. Oncology precision medicine or personalized cancer therapy involves the use of molecular diagnostic tools to identify specific genomic alterations in a patient's tumor which helps physicians select appropriate targeted therapies. Unlike conventional chemotherapy, precision medicine enables customized treatment based on a person's individual genetics, lifestyle and environment. Some key benefits of precision therapies include better treatment response rate, reduced side effects, and ability to target specific cancer mutations.
The Oncology Precision Medicine Market is estimated to be valued at US$ 130 Bn in 2024 and is expected to exhibit a CAGR of 8.9% over the forecast period 2024-2031.
Rising demand for targeted therapies and advancements in genomic profiling technologies are the major factors fueling the growth of this market.
Key Takeaways
Key players operating in the oncology precision medicine are AstraZeneca, Novartis, Pfizer, Bristol-Myers Squibb, and Roche. These companies are engaged in developing novel targeted therapies and combinational regimens of existing drugs.
Continued rise in cancer incidence globally is generating considerable demand for precision therapy approaches. According to WHO, cancer burden is expected to reach 27.5 million new cases and 16.3 million cancer deaths by 2040.
Technological advancements such as next-generation sequencing, bioinformatics and development of companion diagnostics have enabled robust molecular characterization of tumors, which is improving clinical outcomes of precision cancer treatments.
Market Trends
1. Personalized Immunotherapy - Advancements are being made to develop personalized cancer vaccines and immune checkpoint inhibitors tailored to an individual's genetic makeup and tumor mutations. This offers immense potential to enhance immunotherapies response rates.
2. Combinational Therapies - Given emergence of drug resistance, focus is shifting towards combination of targeted drugs and immunotherapies. Numerous ongoing clinical trials are evaluating safety and efficacy of precision therapy combinations.
Market Opportunities
1. Liquid Biopsy Applications - Non-invasive liquid biopsies offer promise for real-time tumor monitoring and detection of acquired resistance. Growing research on liquid biopsy mediated precision therapies can expand market opportunities.
2. Emerging Markets - Lower penetration of precision oncology in developing nations compared to developed countries presents significant scope for future market expansion.
Impact Of COVID-19 On Oncology Precision Medicine Market Growth
The COVID-19 pandemic has significantly impacted the growth of the oncology precision medicine market. In the initial phases, various restrictions imposed to curb the spread of infection disrupted the supply chain and halted clinical trials. Production and supply of critical ingredients used in targeted therapies and immunotherapies faced delays. This caused shortages of some molecular tests used for cancer diagnosis and tumor profiling.
However, with progress in vaccination and adaptation to new safety protocols, the market is recovering fast. Telehealth and digital platforms played a key role in continuing remote consultation and treatment supervision during lockdowns. This boosted demand for companion diagnostics and biomarkers to optimize targeted treatments. Partnerships between pharmaceutical companies and diagnostic labs expanded disease monitoring and management capacities.
Investments in genomic and artificial intelligence-driven research accelerated during the pandemic to develop effective precision approaches against coronavirus. This is rapidly expanding knowledge applicable to personalized oncology. Growing focus on treatment individualization as per immune response and risk factors will boost post-COVID growth. Affordability of localized molecular testing is improving with increased production capacities.
Geographical Regions With High Oncology Precision Medicine Market Concentration
North America accounts for the largest share of the oncology precision medicine market value currently. This is attributed to broader healthcare insurance coverage and early adoption of novel targeted and immunotherapies. Comprehensive biomarker testing and genomic profiling are routinely used for selecting the right treatment pathway in the US and Canada.
Western Europe is another major revenue generator with high acceptance of precision diagnosis and therapies. Government-funded universal healthcare and stringent regulatory approval mechanisms fosters innovation. Asia Pacific is emerging as the fastest growing regional market. Developing nations like China and India are making huge investments in advancing their precision oncology infrastructure and capabilities.
Geographical Region Witnessing Fastest Growth In Oncology Precision Medicine Market
Asia Pacific region is projected to witness the fastest growth in the oncology precision medicine market during the forecast period. This is owing to rising cancer incidence, growing healthcare expenditure, increasing public-private collaborations and regulatory reforms to facilitate novel diagnostics and therapies.
Countries like China, South Korea and Japan are rapidly building genomic and clinical trial capacities to meet domestic demand and emerge as global precision medtech hubs. India is promoting medical tourism with competitive costs and a large patient pool benefiting from access to targeted medicines. Initiatives to strengthen diagnostic labs, train oncologists and establish tech-driven research facilities will further accelerate APAC's market expansion.
Get more insights on this topic: https://www.ukwebwire.com/oncology-precision-medicine-market-is-estimated-to-witness-high-growth-owing-to-advancements-in-cancer-genomics/
Author Bio:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. (LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )
What Are The Key Data Covered In This Oncology Precision Medicine Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Oncology Precision Medicine 's growth between 2024 and 2031.
:- Accurate calculation of the size of the Oncology Precision Medicine and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Oncology Precision Medicine Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Oncology Precision Medicine vendors
FAQ’s
Q.1 What are the main factors influencing the Oncology Precision Medicine ?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Oncology Precision Medicine companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Oncology Precision Medicine ’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it
#Oncology Precision Medicine Market Trend#Oncology Precision Medicine Market Size#Oncology Precision Medicine Market Information#Oncology Precision Medicine Market Analysis#Oncology Precision Medicine Market Demand
0 notes
Text
Covishield Side Effects: What You Need to Know After 2 Years
Covishield, the Indian-made soldier in the fight against COVID-19, has become a household name. Millions across the globe have received this vaccine, and with time comes the natural question: what about Covishield side effects two years down the line? This article delves deeper, exploring both the well-known short-term effects and navigating the murky waters of potential long-term concerns.
Short-Term Jitters: A Common Occurrence
The good news? Most reported Covishield side effects are like fleeting visitors, arriving shortly after vaccination and departing within a few days. These temporary inconveniences are your body's immune system kicking into gear, a sign the vaccine is doing its job. Here's a breakdown of these common short-term companions: - Injection Site Woes: A familiar ache or soreness at the injection site is a frequent guest. Think of it as a mild muscle strain that fades away within a day or two. - Feverish Discomfort: A slight fever is another guest you might encounter. This low-grade rise in body temperature is your immune system's response, easily managed with over-the-counter pain relievers. - Fatigue: The Post-Vaccination Slump: Feeling drained or sluggish is a common complaint. Don't fight it – listen to your body and prioritize rest and hydration. - Headache Hijinks: Let's face it, headaches are unwelcome visitors anywhere. The good news is, these post-vaccination headaches tend to be short-lived and resolve on their own. - Muscle Aches and Chills: A slight shiver or muscle soreness might join the party. These are usually short-lived and can be soothed with rest and over-the-counter pain relievers.
The Rare Blood Clot Risk: Knowledge is Power
Blood Clot or thrombus blocking the red blood cells stream within an artery or a vein 3D rendering illustration. Thrombosis, cardiovascular system, medicine, biology, health, anatomy, pathology concepts. While short-term effects are manageable, there's a very rare side effect associated with the AstraZeneca vaccine, including Covishield, called Thrombosis with Thrombocytopenia Syndrome (TTS). TTS involves blood clots developing in unusual locations along with a decrease in blood platelets. The risk of developing TTS is extremely low, estimated to be around 4-8 cases per million vaccinations. However, being aware of the signs and symptoms of TTS is crucial. These may include: - A persistent, worsening headache - Blurred vision or difficulty seeing - Difficulty breathing or chest pain - Leg swelling or pain - Persistent abdominal pain If you experience any of these symptoms after receiving the Covishield vaccine, seek immediate medical attention. Early diagnosis and treatment are key in managing TTS.
The Long-Term Landscape: Navigating Uncertainty
World of blue question mark. Elements of this image furnished by NASA. Since COVID-19 vaccines are a relatively new development, there's a lack of long-term data (beyond 2 years) on potential Covishield side effects. However, this doesn't necessarily translate to hidden risks. Extensive safety monitoring is ongoing by the World Health Organization (WHO) and other health organizations to assess the long-term safety of all COVID-19 vaccines, including Covishield.
Reliable Sources for Covishield Side Effect Information: Don't Get Lost in the Maze
With the ever-changing information landscape surrounding COVID-19 vaccines, relying on credible sources for updates on Covishield side effects is paramount. Here are some trustworthy resources you can consult: - World Health Organization (WHO): https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know - Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html
When in Doubt, Talk it Out: Consulting Your Healthcare Professional
If you have any specific concerns related to Covishield side effects after receiving the vaccine, consult a healthcare professional. They can address your individual questions and concerns based on your medical history and any specific symptoms you may be experiencing.
The Final Word: Knowledge is Power
Covishield has been a crucial weapon in the fight against COVID-19. While most reported Covishield side effects are short-term and mild, it's important to be aware of the rare blood clot risk (TTS) and to seek immediate medical attention if you experience any concerning symptoms. The lack of long-term data beyond two years doesn't necessarily indicate long-term risks, and ongoing monitoring efforts by health organizations are in place. For the most up-to-date and reliable information on Covishield side effects, consult trustworthy health resources or schedule an appointment with your doctor. Read the full article
#bloodclots#COVID-19vaccine#Covishield#immunity#long-termeffects#short-termeffects#sideeffects#thrombocytopenia#TTS#Vaccination#who#WorldHealthOrganization
0 notes
Text
Covid Tongue - The new symptom of coronavirus infection
The globe has seen several unexpected developments since the Corona pandemic began. Even minor physical symptoms during the pandemic, such as a fever, headache, or dry cough, might cause people to become anxious and nervous.
COVID Tongue is one of the less well-known COVID-19 symptoms that has to do with oral health. This illness is characterized by peculiar rashes, especially on the tongue and toes, and a decreased sensation of taste.
COVID-19 The tongue appears as lumps and enlargements on the outside, frequently with dark or red areas that mimic a geographic tongue. Those who experience weariness and headaches in addition to these abnormalities in the tongue should be on the lookout for signs of a coronavirus infection.
It is commonly known that mucous membranes, including the tongue, are susceptible to bacterial infection. Studies reveal that ACE (Angiotensin-Converting Enzyme) is abundantly present on the tongue's surface and acts as the coronavirus's main site of attachment. As a result, the virus may spread and infect people, which could result in COVID Tongue.
COVID-19 treatment The etiology of tongue is yet unknown, thus it continues to be elusive. It is important to remember that dental disorders other than COVID-19 can cause abnormalities of the tongue and discomfort in the mouth. However, it's critical to see a doctor right away to rule out COVID-19 infection if accompanied by symptoms like exhaustion, coughing, and shortness of breath.
If a person tests positive for COVID-19, they will be given individualized treatment plans, recommended drugs, and instructions on how to follow quarantine rules to treat the virus and its side effects, such as abnormalities in the tongue.
It is important to stress that maintaining good hygiene habits, such often washing your hands, sterilizing them, donning masks, and keeping social distance from others, is still essential to preventing the transmission of COVID-19 and its oral manifestations. Although vaccinations provide hope, questions remain about how the virus may affect people's health in the long run.
In conclusion, being watchful and following advised precautions will help protect against COVID Tongue and other possible side effects of the infection.
FOR MORE INFO PLEASE VISIT : https://www.suryadentalcare.com/covid-tongue-the-new-symptom-of-coronavirus-infection/
0 notes
Text
Global Osteoarthritis Market: Trends, Treatment, and Projections 2030
Report Summary
In 2023, the worldwide osteoarthritis market was valued at USD 7.40 billion and is predicted to increase at an 8.5% CAGR during the forecast period 2023-2030. Both the introduction of analgesic drugs and the development of imaging diagnostics based on radiographic characteristics are stimulating market growth. Increased expenditure on healthcare infrastructure and expanding investments in research and development (R&D) efforts to bring novel diagnostics and biomarkers are also driving the market.
Osteoarthritis (OA) is a group of disorders that affect the joints of the knees, hips, fingers, foot, back, shoulders, and neck. It is distinguished by the gradual degeneration of the cartilage in these joints. Stiffness, edoema, discomfort, persistent pain, loss of flexibility, a grating sensation, bone spurs, and sleep interruptions are all common symptoms of OA.
Click here for full report:
Medical examination, X-rays, arthroscopy, joint fluid analysis, lab testing, and magnetic resonance imaging (MRI) scans can all be used to diagnose it. Depending on the outcomes, different medications and surgical techniques are prescribed to treat the disease's signs and symptoms. There are presently alternative medicines, physical therapy, and supporting devices on the market to relieve pain and improve joint function.
Sedentary lifestyles, poor eating habits, and increasing weight and blood sugar levels make people more susceptible to develop OA. This is one of the primary driving drivers for market development, combined with an ageing population that is more susceptible to such disorders. Furthermore, the ease of access to MRI scans is a key growth-promoting factor.
The COVID-19 outbreak is predicted to have only a minimal influence on the osteoarthritis therapy industry. Corticosteroids are being used less often in many medicine types. Although there is no evidence that corticosteroid injections significantly increase the risk of infection, the immune system may be less active for a few weeks following surgery.
Even though the risk is extremely minimal, it should be taken into account before starting with the procedure. It should be noted that the World Health Organisation cautioned against the use of systemic corticosteroids in one of its guidelines for treating severe acute respiratory infections caused by coronavirus.
Industry Dynamics
Growth Drivers:
Increased government investment on cell-based research, as well as the increasing use of opioids, are driving market expansion. Topical, oral, and analgesic medications are commonly used to treat osteoarthritis pain. Even if alternatives such as orthopaedic braces are used as part of a noninvasive approach to pain therapy, the adoption of pain pills for the disease is substantial due to the ease of administration and the cost of pain medications. Oral analgesics such as acetaminophen, NSAIDs, intra-articular medicines, and nutraceuticals are all common pain relievers.
Personalised OA medications have also been proposed, which would represent a considerable advance in the diagnosis, therapy, and monitoring of disease severity in osteoarthritis patients. Simple measurement, appropriate levels of sensitivity and specificity, and test procedures available to and interpretable by clinicians are critical qualities of indicators of therapeutic relevance for a personalised approach to OA therapy.
The use of biomarkers to identify individuals who are most likely to respond to specific medical therapies may increase treatment response rates and reduce the risk of exposing patients to medicines that are either unlikely to be effective or may cause harmful side effects from their treatment. Using a mix of unique biomarkers and baseline clinical parameters such as age and gender might be beneficial.
Report Segmentation
The market is primarily segmented based on treatment type, disease type, distribution channel, route of administration, and region.
Click here for full report:
Knee Osteoarthritis segment is expected to witness fastest growth
Personalised OA medications have also been proposed, which would represent a considerable advance in the diagnosis, therapy, and monitoring of disease severity in osteoarthritis patients. Simple measurement, appropriate levels of sensitivity and specificity, and test procedures available to and interpretable by clinicians are critical qualities of indicators of therapeutic relevance for a personalised approach to OA therapy.
Furthermore, increased FDA approvals for the treatment of Knee OA are driving sector growth throughout the projection period. For example, Novartis announced in September 2021 that LNA043 had been granted fast-track designation by the US Food and Drug Administration (FDA) for knee osteoarthritis rehabilitation.
Drugs targeted to treat severe diseases and address unmet medical needs can be created more swiftly and evaluated more quickly. LNA043, a possibly first-in-class disease-modifying treatment for osteoarthritis, is being developed. As a result, growing approvals for the treatment of knee OA drive market development throughout the projection period.
Click here for free sample request:
Viscosupplementation segment industry accounted for the highest market share in 2021
The rising prevalence of knee osteoarthritis is the key driver of this market's expansion. By injecting synovial fluid into the afflicted joints, which increases lubrication, viscosupplementation greatly lowers osteoarthritis discomfort. Furthermore, the market for viscosupplementation agents is expected to grow considerably over the forecast period due to the discovery of novel viscosupplementation agents and government efforts to boost research in the healthcare sector.
Hospital Pharmacies are expected to hold the significant revenue share
Hospital pharmacies retained the largest share of this market due to the large number of patients seeking treatment for osteoarthritis in hospitals and the vast assortment of osteoarthritis drugs available in these pharmacies. Another important advantage is the ease with which hospital pharmacy purchases may be reimbursed.
The demand in North America is expected to witness significant growth
A rise in the frequency of chronic diseases, an increase in the number of elderly people, and changes in people's lifestyles all contribute to the anticipation of market expansion in North America. As a result, the region is incorporating an increasing number of treatments and drugs. When compared to Canada and Mexico, the United States will command a substantial share of the North American market for osteoarthritis therapies.
According to the CDC, osteoarthritis (OA), the most common kind of arthritis, is a severe chronic illness that affects 32.5 million individuals in the United States. OA is associated with ageing and is more common in those with other chronic conditions such as obesity, diabetes, and heart disease. However, 18.7 million people with OA, or more than half of them, are of working age (18 to 64 years).
Furthermore, the availability of better treatment alternatives, government reimbursement guidelines, increased research and development activities in the creation of novel medicines, and the introduction of new therapies in the North American region are all expected to support market expansion in the region.
Europe controlled the market for osteoarthritis therapies. The increased incidence of osteoarthritis, the ageing population, rising obesity rates in several European countries, and the growing number of sports- and accident-related injuries all contribute to this sector's large market share.
#Global Osteoarthritis Market#osteoarthritis market#osteoarthritis treatment#global arthritis trends#osteoarthritis research#arthritis therapies#osteoarthritis prognosis#joint disease market#arthritis medication
0 notes
Text
Exploring the Frontiers of Science: Lung Cell Culture and its Implications in Research and Medicine
Introduction:
Lung cell culture, a sophisticated technique in cell biology, plays a pivotal role in advancing our understanding of respiratory diseases, drug development, and personalized medicine. This technique involves the extraction and cultivation of lung cells outside the body in a controlled environment, providing researchers with a powerful tool to study cellular processes, test new drugs, and develop innovative therapies. In this article, we will delve into the intricacies of lung cell culture, its applications, and the profound impact it has on scientific research and medical advancements.
Fundamentals of Lung Cell Culture:
Lung cell culture begins with the isolation of cells from lung tissues, either from animal models or human donors. The cells are then placed in a nutrient-rich medium that mimics the conditions found within the body. This artificial environment supports the cells' growth, allowing them to proliferate and form a monolayer or three-dimensional structures, depending on the research goals.
Primary cells, derived directly from tissues, and immortalized cell lines, which can divide indefinitely, are the two main types of cells used in lung cell culture. Primary cells are preferred when studying specific physiological processes, while immortalized cell lines provide a consistent and reproducible platform for large-scale experiments.
Applications of Lung Cell Culture:
Disease Modeling:
Lung cell culture has revolutionized the modeling of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. By culturing cells from affected individuals or utilizing genetically modified cells, researchers can recreate disease conditions in vitro. This allows for the study of disease mechanisms, identification of potential therapeutic targets, and the development of more effective treatments.
Drug Discovery and Development:
The pharmaceutical industry heavily relies on lung cell culture for drug discovery and development. Testing potential drugs on cultured lung cells provides valuable insights into their efficacy, toxicity, and potential side effects. This step is crucial in the early stages of drug development, helping researchers identify promising candidates and eliminate those with unfavorable characteristics before moving to expensive and time-consuming clinical trials.
Infection Studies:
Lung cell culture is instrumental in studying respiratory infections caused by viruses, bacteria, and fungi. Researchers can infect cultured cells with pathogens to understand the host-pathogen interactions, immune responses, and the development of antiviral or antibacterial therapies. This approach has been particularly valuable in the study of respiratory viruses such as influenza and the coronavirus.
Toxicology Studies:
Evaluating the toxic effects of various substances on lung cells is another important application. Researchers can expose cultured cells to pollutants, chemicals, or other environmental factors to assess their impact on cellular function and viability. This information is crucial for understanding the potential risks associated with exposure to different substances and for establishing safety guidelines.
Stem Cell Research:
Lung cell culture is also integral to stem cell research aimed at regenerative medicine. By manipulating stem cells in culture, researchers can guide their differentiation into specific lung cell types. This approach holds promise for repairing damaged lung tissue and developing cell-based therapies for conditions like pulmonary fibrosis.
Challenges and Future Directions:
While lung cell culture has significantly advanced our understanding of respiratory biology, it comes with its own set of challenges. Culturing cells in an artificial environment may not fully replicate the complex interactions and conditions present in the human body. Researchers continually strive to improve culture systems to better mimic in vivo environments, incorporating factors like airflow, mechanical strain, and the three-dimensional architecture of lung tissue.
Moreover, the heterogeneity of lung cell populations adds another layer of complexity. Different cell types, including alveolar epithelial cells, bronchial epithelial cells, and immune cells, each have distinct characteristics. Researchers are working to develop more specialized culture techniques that account for this diversity, allowing for more precise and meaningful experiments.
As technology advances, lung cell culture is likely to become even more sophisticated. The integration of microfluidics, 3D bioprinting, and organ-on-a-chip technologies holds promise for creating in vitro models that closely resemble the complex structure and function of the human lung. These innovations could enhance the accuracy of drug testing, disease modeling, and toxicology studies, bringing us closer to personalized medicine tailored to individual patient profiles.
Conclusion:
Lung cell culture stands at the forefront of scientific and medical research, offering a versatile platform for studying respiratory diseases, testing drugs, and advancing regenerative medicine. Its applications extend across a spectrum of disciplines, from basic cellular biology to drug discovery and development. Despite the challenges, researchers continue to refine and innovate in the field, pushing the boundaries of what is possible.
As our understanding of lung cell biology deepens and technology continues to evolve, the impact of lung cell culture on healthcare and medicine is likely to expand. This technique holds the key to unlocking new insights into respiratory diseases, paving the way for more effective treatments and personalized therapeutic approaches.
1 note
·
View note
Text
Vitamin C (Ascorbic Acid) - Uses, Side Effects, And More
Possibly Ineffective for
Short-term swelling (inflammation) of the airways in the lungs (acute bronchitis). Taking vitamin C by mouth does not seem to have any effect on bronchitis.
Asthma. Taking vitamin C by mouth doesn't seem to prevent asthma or improve symptoms in people who already have asthma.
Hardening of the arteries (atherosclerosis). Taking vitamin C by mouth does not seem to prevent atherosclerosis from becoming worse in most people with this condition.
Bladder cancer. Taking vitamin C by mouth does not seem to prevent bladder cancer or reduce bladder cancer-related deaths.
Heart disease. Taking vitamin C by mouth does not prevent heart disease or reduce death due to heart disease.
Colon cancer, rectal cancer. Taking vitamin C by mouth does not seem to prevent cancer in the colon or rectum.
Coronavirus disease 2019 (COVID-19). Taking high-dose vitamin C by mouth does not seem to speed up recovery from COVID-19 in people who aren't in the hospital. Giving vitamin C by mouth or IV to people who are in the hospital with severe COVID-19 might have some benefit, but more studies are needed to say for sure.
Death of an unborn or premature baby. Taking vitamin C by mouth, alone or with other supplements, during pregnancy doesn't prevent death of an unborn or premature baby.
Fractures. Taking vitamin C by mouth does not seem to improve function, symptoms, or healing rates in people with a wrist fracture.
A digestive tract infection that can lead to ulcers (Helicobacter pylori or H. pylori). Taking vitamin C by mouth along with medicines used to treat H. pylori infection doesn't seem to get rid of H. pylori faster than taking the medicines alone.
A group of inherited disorders that leads to muscle weakness and numbness in the arms and legs. Taking vitamin C by mouth for one or two years does not seem to prevent nerve damage in people with these disorders.
Eye damage in people taking drugs called interferons (interferon-related retinopathy). Taking vitamin C by mouth does not seem to prevent eye damage in people receiving interferon therapy for liver disease.
Cancer of the white blood cells (leukemia). Taking vitamin C by mouth doesn't seem to prevent leukemia or death due to leukemia.
Lung cancer. Taking vitamin C by mouth, alone or with vitamin E, doesn't seem to prevent lung cancer or death due to lung cancer.
The most serious type of skin cancer (melanoma). Taking vitamin C by mouth, alone or with vitamin E, doesn't prevent melanoma or death due to melanoma.
Miscarriage. Taking vitamin C by mouth, alone or with other supplements, during pregnancy does not prevent miscarriage.
Death from any cause. Taking vitamin C by mouth along with other antioxidants does not seem to prevent death.
Pancreatic cancer. Taking vitamin C by mouth together with beta-carotene plus vitamin E does not seem to prevent pancreatic cancer.
A pregnancy complication marked by high blood pressure and protein in the urine (pre-eclampsia). Taking vitamin C by mouth with vitamin E during pregnancy does not prevent high blood pressure and protein in the urine during pregnancy.
Preterm birth. Taking vitamin C by mouth, alone or with other supplements, during pregnancy does not prevent preterm birth.
Prostate cancer. Taking vitamin C by mouth does not seem to prevent prostate cancer.
Skin damage caused by radiation therapy (radiation dermatitis). Applying a vitamin C solution to the skin does not prevent skin problems caused by radiation treatments.
Infants with birth weight below the 10th percentile. Taking vitamin C by mouth, alone or with other supplements, during pregnancy does not reduce the chance of giving birth to an infant with a low birth weight.
Stillbirth. Taking vitamin C by mouth, alone or with other supplements, during pregnancy does not reduce the chance of having a stillbirth.
There is interest in using vitamin C for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful.
Likely InEffective for
Blood infection (sepsis). Giving vitamin C by IV with or without thiamine and/or a steroid does not reduce the risk of dying, organ damage, hospitalization duration, or the need for supportive treatment in people with sepsis. -
0 notes
Text
Amoxicillin Market Recent Advancements and Future Challenges
The Amoxicillin market, a vital component of the global pharmaceutical landscape, is poised for significant growth and transformation by 2032. This article explores the top winning strategies that will shape the future of the Amoxicillin market and its role in addressing infectious diseases and improving global healthcare.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐎𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-toc-and-sample/11484
COVID-19 scenario analysis:
The Pharmaceutical and biotech companies have joined together with governments around the globe in order to manage COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Furthermore there is various development initiatives carried out such that around 115 vaccine candidates and 155 molecules are expected to help in management of coronavirus disease -2. Moreover, the drugs which are successfully showing its effect on the patient such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. The high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. The rise in demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
1. Research and Development Advancements
One of the cornerstones of the Amoxicillin market's future success is the continued investment in research and development. Pharmaceutical companies are committed to enhancing the efficacy and safety of Amoxicillin formulations, potentially reducing side effects and improving patient compliance. This includes exploring novel delivery methods, combination therapies, and the development of pediatric formulations to make Amoxicillin more accessible for children.
2. Focus on Generic Variants
As patents for branded Amoxicillin products expire, generic variants will play a pivotal role in expanding market reach. Generic drug manufacturers will employ strategies to produce cost-effective versions of Amoxicillin, making the medication more affordable and accessible to a broader population.
3. Antibiotic Stewardship Initiatives
The rise of antibiotic resistance has heightened the importance of responsible antibiotic use. Pharmaceutical companies and healthcare providers are embracing antibiotic stewardship programs to promote the rational use of antibiotics like Amoxicillin. By ensuring the right antibiotic is prescribed for the right duration and at the right dose, the industry aims to combat resistance and prolong the effectiveness of these critical medications.
𝐏𝐫𝐞-𝐛𝐨𝐨𝐤 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/amoxicillin-market/purchase-options
4. Global Market Expansion
The Amoxicillin market is extending its reach globally, with a focus on emerging markets. As healthcare infrastructure improves in developing countries, the demand for antibiotics, including Amoxicillin, is expected to grow. Companies are formulating strategies to meet this increasing demand, ensuring a stable supply of antibiotics where they are most needed.
5. Sustainable Practices
Pharmaceutical companies are increasingly adopting sustainable and environmentally responsible practices in the production and distribution of Amoxicillin. Reducing waste, conserving resources, and adopting eco-friendly packaging options are part of the industry's broader sustainability efforts.
6. Education and Awareness
Education and awareness campaigns are key components of the winning strategies for the Amoxicillin market. These efforts target both healthcare professionals and the public, aiming to raise awareness about responsible antibiotic use, the importance of completing prescribed courses, and the dangers of self-medication.
7. Regulatory Compliance
Adherence to stringent regulatory standards and quality control measures is paramount in the Amoxicillin market. Companies are committed to ensuring product quality and safety, meeting international regulatory requirements, and maintaining Good Manufacturing Practices (GMP).
Inquire Before Buying : https://www.alliedmarketresearch.com/purchase-enquiry/11484
In conclusion, the Amoxicillin market by 2032 will be characterized by responsible antibiotic use, enhanced formulations, increased accessibility, and a stronger commitment to sustainability. These winning strategies are not only reshaping the industry but also contributing to the global fight against infectious diseases and antibiotic resistance, ensuring that Amoxicillin remains a critical tool in modern healthcare. The future of Amoxicillin holds promise, not just for the pharmaceutical industry but for public health on a global scale.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
1 note
·
View note
Text
Unraveling the Web of Digestive Disorders: Insights from Dr. Rupesh Lunkad, Best Gastroenterologist in Pune
Introduction
In the intricate orchestra of our bodily functions, the digestive system plays a pivotal role. However, it's not always smooth sailing. Many individuals find themselves grappling with various digestive disorders that can disrupt daily life. To shed light on these common issues, we turn to Dr. Rupesh Lunkad, recognized as the best gastroenterologist in Pune, whose expertise has unraveled the mysteries of digestive health for countless patients.
Understanding Digestive Disorders
Digestive disorders encompass a wide spectrum of conditions that affect the gastrointestinal (GI) tract. From mild inconveniences to severe health issues, these disorders can manifest in diverse ways, making early recognition and intervention crucial.
Dr. Lunkad emphasizes the value of recognizing side effects and seeking appropriate therapeutic advice. Stomach-related problems can range from simple cases of heartburn to more complicated ones like inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS). Every case is unique, and a tailored approach to conclusion and treatment is essential.
Common Digestive Disorders
Gastroesophageal Reflux Disease (GERD): GERD is a chronic condition where stomach acid flows back into the esophagus, causing symptoms like heartburn and regurgitation. Dr. Lunkad highlights lifestyle modifications and medications as key components of managing GERD.
Irritable Bowel Syndrome (IBS): IBS is a functional GI disorder characterized by abdominal pain, bloating, and changes in bowel habits. Dr. Lunkad emphasizes the role of a balanced diet, stress management, and medications tailored to individual symptoms in managing IBS.
Inflammatory Bowel Disease (IBD): Crohn's disease and ulcerative colitis are two types of IBD that cause chronic inflammation in the digestive tract. Dr. Lunkad stresses the importance of a multidisciplinary approach, including medications, nutritional therapy, and, in some cases, surgery.
Celiac Disease: An autoimmune disorder triggered by gluten consumption, celiac disease can damage the small intestine. Dr. Lunkad underscores the necessity of a strict gluten-free diet and nutritional support for those with celiac disease.
Peptic Ulcers: Open sores that develop on the inner lining of the stomach, small intestine, or esophagus, peptic ulcers can cause pain and discomfort. Dr. Lunkad discusses the role of medications to reduce stomach acid, antibiotics for H. pylori infection, and lifestyle changes in managing peptic ulcers.
Prevention and Lifestyle Modifications
Preventing digestive disorders often involves adopting healthy lifestyle habits. Dr. Lunkad advises a balanced diet rich in fiber, regular exercise, adequate hydration, and stress management. "These lifestyle modifications are not only essential for preventing digestive issues but also play a crucial role in managing existing conditions," he emphasizes.
The Importance of Regular Check-ups
Maintaining stomach-related health requires routine visits to a gastroenterologist. In particular for people who have a family history of digestive problems or who are suffering from severe side effects, Dr. Lunkad suggests routine testing. "Early location can altogether affect the course of treatment and work on long haul results," he said.
Navigating the Future of Digestive Health
As innovation propels, so does the area of gastroenterology. Dr. Lunkad examines the job of imaginative symptomatic apparatuses and medicines in forming the eventual fate of stomach related medical care. " Progressions like virtual colonoscopies, container endoscopies, and negligibly obtrusive strategies are changing the manner in which we analyze and treat stomach related messes," he notes.
Telemedicine in Gastroenterology
The coronavirus epidemic hastened the adoption of telemedicine in healthcare. Dr. Lunkad discusses the advantages of telemedicine for gastrointestinal problems, including remote consultations and patient observation. "Telemedicine permits us to arrive at patients who might confront boundaries to in-person visits, guaranteeing congruity of care and convenient mediations," he says.
Patient Education and Empowerment
Dr. Lunkad has a strong desire to improve his comprehension of lessons. He acknowledges that empowered patients are those who are well-informed. Understanding your body and the elements that contribute to your overall welfare in terms of your stomach is the most important step in action and the executives. I encourage my patients to actively participate in their search for medical care and to seek clarification on some problems, he says.
Conclusion
Digestive disorders are intricate and diverse, but with the guidance of experts like Dr. Rupesh Lunkad, individuals can navigate these challenges with resilience. By promoting awareness, emphasizing prevention, and leveraging the latest advancements in gastroenterology, Dr. Lunkad continues to make a significant impact on digestive health in Pune and beyond. Remember, your digestive health matters—take the steps today for a healthier tomorrow.
#gastroenterologist#gastroenterology#colonoscopy#endoscopy#doctor#gerd#health#gastroenterologia#medical#coloncancer#medicine#tifprocedure#healthcare#covid#gastro#localphysicians#gastroscopy#BestGastroenterologistinPune#Endoscopydoctorinpune#BestLiverSpecialistdoctorinpune#Hepatologistinpune#GastrologistinPune
1 note
·
View note